FDA Inspection 1281564 — Patheon Pharmaceuticals Inc.

Patheon Pharmaceuticals Inc. — FEI 1510437

The FDA completed an inspection of Patheon Pharmaceuticals Inc. on Sep 26, 2025 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 26, 2025
Fiscal Year
2025
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Cincinnati, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.